Akorn-Fresenius Fight Over Canceled Deal Is Argued in Court

Bookmark
(Bloomberg) -- Akorn Inc., still trying to salvage its multibillion-dollar sale to German drugmaker Fresenius SE, argued that a trial judge improperly rewrote state law and used “guesswork” in allo...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.